Profile | Published:

Greg Winter

Nature Biotechnology volume 29, page 190 (2011) | Download Citation

Subjects

The inventor of humanized monoclonal antibodies and cofounder of Cambridge Antibody Technology, Greg Winter, muses on the future of antibody therapeutics and UK life science innovation.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nbt.1815

Authors

    Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing